Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Working Capital Changes (2016 - 2025)

Ptc Therapeutics has reported Other Working Capital Changes over the past 14 years, most recently at $22.9 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $22.9 million for Q4 2025, up 149.53% from a year ago — trailing twelve months through Dec 2025 was $36.8 million (up 137.28% YoY), and the annual figure for FY2025 was $36.8 million, up 137.28%.
  • Other Working Capital Changes for Q4 2025 was $22.9 million at Ptc Therapeutics, up from $1.7 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PTCT hit a ceiling of $104.5 million in Q4 2023 and a floor of -$93.9 million in Q1 2024.
  • Median Other Working Capital Changes over the past 5 years was $4.7 million (2023), compared with a mean of $2.5 million.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 333.78% in 2021 and later surged 19843.18% in 2022.
  • Ptc Therapeutics' Other Working Capital Changes stood at $23.5 million in 2021, then crashed by 31.81% to $16.0 million in 2022, then surged by 552.62% to $104.5 million in 2023, then tumbled by 91.2% to $9.2 million in 2024, then surged by 149.53% to $22.9 million in 2025.
  • The last three reported values for Other Working Capital Changes were $22.9 million (Q4 2025), $1.7 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.